drugs
Investing.com — The Federal Trade Commission (FTC) has released a report showing that the three largest pharmacy benefit managers (PBMs) in the industry have significantly marked up prices on specialty generic drugs. The PBMs, Caremark Rx, LLC, Express Scripts, Inc., and OptumRx, Inc., are all owned by major healthcare conglomerates.…
By Deena Beasley (Reuters) -Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with obesity-related conditions or take the drugs to become eligible for other services, health records and discussions with doctors show. An exclusive analysis of hundreds of thousands of electronic patient…
By Patrick Wingrove (Reuters) – Eli Lilly (NYSE:) said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound, including in the form of dissolvable tablets. The new lawsuits, which name Pivotal Peptides, MangoRx…
Investing.com — Weight-loss medications like the popular versions made by Denmark’s Novo Nordisk A/S (CSE:) and US peer Eli Lilly (NYSE:) are the “most compelling story within the healthcare sector,” analysts at Wells Fargo said. The GLP-1 class of drugs includes blockbuster brands like Novo’s Ozempic and Wegovy and Eli Lilly’s…
Investing.com — Weight-loss medications like the popular versions made by Denmark’s Novo Nordisk A/S (CSE:) and US peer Eli Lilly (NYSE:) are the “most compelling story within the healthcare sector,” analysts at Wells Fargo said. The GLP-1 class of drugs includes blockbuster brands like Novo’s Ozempic and Wegovy and Eli Lilly’s…
By Michael Erman NEW YORK (Reuters) -Sanofi’s chief executive, Paul Hudson (NYSE:), said in an interview on Monday that the company is poised for strong growth from a variety of new drugs and is not facing imminent, costly patent expirations of top-selling products as are some rivals. “We’ve spent five…
By Patrick Wingrove (Reuters) -In December, Drew, a 36-year-old man from San Antonio, Texas, drove more than 250 miles (400 km) to Mexico to buy cheap Ozempic to help him lose weight. Going home, he checked the pens. They looked unusual, so he shared photos on social media. The verdict:…
By Michael Erman (Reuters) – Drugmaker Bristol Myers (NYSE:) Squibb posted better-than-expected second-quarter results, driven by growth from new products like anemia treatment Reblozyl and heart drug Camzyos as well as from its top-seller, blood thinner Eliquis. Eliquis is expected to have revenue curtailed when the U.S. Medicare health plan…
By Brendan Pierson (Reuters) – A U.S. appeals court on Friday refused to block a federal mandate requiring health insurers to cover preventive care services like cancer screenings and HIV-preventing medication at no extra cost to patients, but ruled against the government on a key legal issue that leaves the…
US Senator Bernie Sanders has announced that the CEO of Danish drug company Novo Nordisk will testify on the high cost of the weight-loss drugs Ozempic and Wegovy.Lars Jørgensen will appear on a solo panel before the Senate Committee on Health, Education, Labor, and Pensions (HELP) in September, according to…
